Concepedia

Viktor Boerlin

VB

8

Publications

817

Citations

8

H-Index

1986

Active since

Affiliations

Novartis (Switzerland)(Current)

Erasmus University Rotterdam

Erasmus MC

University of Naples Federico II

Viktor Boerlin is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and preoperative pain.

Top concepts

Publications per year

1986–2015

8

Publications

8

Long-Term Effects of Depot Long-Acting Somatostatin Analog Octreotide on Hormone Levels and Tumor Mass in Acromegaly<sup>1</sup>

Annamaria Colao, Diego Ferone, Paolo Marzullo et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 258 citations · Full text

A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients

Joost van der Hoek, Wouter W. de Herder, Richard A. Feelders et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 142 citations · Full text

Cardiovascular Effects of Depot Long-Acting Somatostatin Analog Sandostatin LAR in Acromegaly*

Annamaria Colao, Paolo Marzullo, Diego Ferone et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 126 citations · Full text

Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly

Philippe Chanson, Viktor Boerlin, Christiane Ajzenberg et al. · Clinical Endocrinology · 2000 · 107 citations

A novel and selective sodium‐glucose cotransporter‐2 inhibitor, tofogliflozin, improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus

Shuta Ikeda, Y. Takano, Osamu Cynshi et al. · Diabetes Obesity and Metabolism · 2015 · 71 citations

Rows per page

1–5 of 8